drugset / Trial / NCT04741789

Managed Access Programs for INC280, Capmatinib

NCT04741789

Expanded access No longer available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to INC280, Capmatinib

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Capmatinib Small molecule Oral